Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR® Implantable Cardioverter-Defibrillator Registry).

[1]  J. Dearani,et al.  Ebstein's Anomaly. , 2019, Methodist DeBakey cardiovascular journal.

[2]  J. Hörer.  Current spectrum, challenges and new developments in the surgical care of adults with congenital heart disease. , 2018, Cardiovascular diagnosis and therapy.

[3]  P. Aziz,et al.  Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time? , 2018, Current Cardiology Reports.

[4]  D. Andreini,et al.  Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study. , 2016, Journal of the American College of Cardiology.

[5]  L. Fauchier,et al.  Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention. , 2016, Heart rhythm.

[6]  K. Dimopoulos,et al.  Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association , 2016, Circulation.

[7]  J. Curtis,et al.  Implant and Clinical Characteristics for Pediatric and Congenital Heart Patients in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry , 2014, Circulation. Arrhythmia and electrophysiology.

[8]  K. Motonaga,et al.  Cardiac Resynchronization Therapy for Pediatric Patients With Heart Failure and Congenital Heart Disease: A Reappraisal of Results , 2014, Circulation.

[9]  K. Sun,et al.  Isolated left ventricular noncompaction: clinical profile and prognosis in 106 adult patients , 2014, Heart and Vessels.

[10]  Yuan Feng,et al.  Percutaneous Transhepatic Venous Access for ICD Implantation in a Patient with Ebstein's Anomaly with Ventricular Tachycardia Post‐Glenn Operation , 2013, Journal of cardiovascular electrophysiology.

[11]  C. Berul,et al.  Multi-Institutional Study of Implantable Defibrillator Lead Performance in Children and Young Adults: Results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) Study , 2013, Circulation.

[12]  A. Go,et al.  Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. , 2013, JAMA.

[13]  I. V. Van Gelder,et al.  Sudden Cardiac Death in Adult Congenital Heart Disease , 1996, Circulation.

[14]  J. Curtis,et al.  Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation , 2011, Circulation.

[15]  J. Curtis,et al.  Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry. , 2010, Journal of the American College of Cardiology.

[16]  T. Lüscher,et al.  Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompaction. , 2010, Heart rhythm.

[17]  M. Chung,et al.  Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2010, Circulation.

[18]  P. Heidenreich,et al.  The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. , 2010, Journal of the American College of Cardiology.

[19]  I. Piña,et al.  Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. , 2010, Heart rhythm.

[20]  J. Rumsfeld,et al.  Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. , 2009, Heart rhythm.

[21]  J. Triedman.  Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenit , 2008, Circulation. Arrhythmia and electrophysiology.

[22]  L. Harris,et al.  Sudden Death and Defibrillators in Transposition of the Great Arteries With Intra-atrial Baffles: A Multicenter Study , 2008, Circulation. Arrhythmia and electrophysiology.

[23]  J. Triedman,et al.  Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.

[24]  L. Harris,et al.  Implantable Cardioverter-Defibrillators in Tetralogy of Fallot , 2008, Circulation.

[25]  P. Barker,et al.  A Patient with Congenital Heart Disease and Ventricular Tachycardia: , 2007, Pacing and clinical electrophysiology : PACE.

[26]  A. Marelli,et al.  Congenital Heart Disease in the General Population: Changing Prevalence and Age Distribution , 2006, Circulation.

[27]  R. Weinstein,et al.  Infection-control report cards--securing patient safety. , 2005, New England Journal of Medicine.

[28]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[29]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.